Global Raw Materials of Longevity Medicine market size is predicted to grow from US$ 3260 million in 2025 to US$ 5021 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032.

Global Raw Materials of Longevity Medicine Market Size, Share and Analysis 2026-32

The global Raw Materials of Longevity Medicine market size is predicted to grow from US$ 3260 million in 2025 to US$ 5021 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032. In 2025, global Raw Materials of Longevity Medicine production reached approximately 6660 tons, with an average global market price of around US$500,000 per ton. In 2025, the global s total production capacity of Raw Materials of Longevity Medicine reached 8320 tons. The industry average gross profit margin of this product reached 39%.Longevity drug ingredients refer to a series of active substances that are considered in scientific research to have the potential to intervene in the aging process, extend healthy lifespan, or alleviate age-related diseases. These are not strictly approved drugs, but rather compounds or natural ingredients at different stages of research and development. They primarily function by regulating core biological pathways related to aging, such as activating longevity proteins, increasing NAD+ levels, inhibiting mTOR, promoting autophagy, or selectively clearing senescent cells. Their scope includes everything from natural extracts to chemically synthesized compounds, as well as prescription molecules for drug repurposing, collectively forming the material basis for current cutting-edge anti-aging research. The longevity drug raw material industry chain has initially formed a vertical chain from basic research to marketable products. Upstream, academic institutions and biotechnology companies are at the core, focusing on aging mechanism research, target discovery, and the synthesis or extraction of raw materials. Midstream is dominated by R&D-oriented pharmaceutical and health product companies, conducting raw material formulation development, efficacy verification, and formulation production. Downstream, it reaches consumers through multiple channels: prescription raw materials are strictly limited to clinical research; while raw materials as dietary supplements enter the market through e-commerce, professional channels, and cross-border trade. Regulatory policies and capital investment permeate the entire chain, driving its development towards compliance and industrialization. The longevity drug raw material market has broad prospects but also faces challenges, and its development will exhibit three major trends. At the market level, with the increasing global aging population and the upgrading of health consumption, the supplement market, represented by NMN, has grown rapidly, while more promising prescription-level therapies are attracting huge amounts of capital, driving clinical translation. At the technological level, research is shifting from single-component studies to multi-target combinations and personalized interventions; gene technology, AI screening, and biomanufacturing will accelerate the discovery of a new generation of highly effective and safe raw materials. In terms of regulation and awareness, the regulatory framework is gradually exploring how to evaluate the indication of anti-aging, and the results of large-scale clinical studies are expected to provide key evidence for the industry. Infinity Market Research newest research report, the Raw Materials of Longevity Medicine Industry Forecast looks at past sales and reviews total world Raw Materials of Longevity Medicine sales in 2025, providing a comprehensive analysis by region and market sector of projected Raw Materials of Longevity Medicine sales for 2026 through 2032. With Raw Materials of Longevity Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Raw Materials of Longevity Medicine industry. This Insight Report provides a comprehensive analysis of the global Raw Materials of Longevity Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Raw Materials of Longevity Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Raw Materials of Longevity Medicine market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Raw Materials of Longevity Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Raw Materials of Longevity Medicine. This report presents a comprehensive overview, market shares, and growth opportunities of Raw Materials of Longevity Medicine market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Purity ? 98% &nbsp;&nbsp;&nbsp; Purity < 98% &nbsp;&nbsp;&nbsp; Segmentation by Types of Raw Materials: &nbsp;&nbsp;&nbsp; NMN (Nicotinamide Mononucleotide) &nbsp;&nbsp;&nbsp; NR (Nicotinamide Riboside) &nbsp;&nbsp;&nbsp; Resveratrol &nbsp;&nbsp;&nbsp; Metformin &nbsp;&nbsp;&nbsp; Astaxanthin &nbsp;&nbsp;&nbsp; Coenzyme Q10 &nbsp;&nbsp;&nbsp; Others &nbsp;&nbsp;&nbsp; Segmentation by Sources and Chemical Properties: &nbsp;&nbsp;&nbsp; Natural Extracts &nbsp;&nbsp;&nbsp; Chemical Synthesis &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Health Products &nbsp;&nbsp;&nbsp; Medicines &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; DSM &nbsp;&nbsp;&nbsp; Evolva &nbsp;&nbsp;&nbsp; Sabinsa &nbsp;&nbsp;&nbsp; InterHealth &nbsp;&nbsp;&nbsp; Maypro &nbsp;&nbsp;&nbsp; Laurus Labs &nbsp;&nbsp;&nbsp; JF-NATURAL &nbsp;&nbsp;&nbsp; GeneHarbor &nbsp;&nbsp;&nbsp; Herbalmax &nbsp;&nbsp;&nbsp; Genex Formulas &nbsp;&nbsp;&nbsp; Mirailab Bioscience &nbsp;&nbsp;&nbsp; Maac10 Formulas &nbsp;&nbsp;&nbsp; EffePharm &nbsp;&nbsp;&nbsp; Bontac &nbsp;&nbsp;&nbsp; CELFULL &nbsp;&nbsp;&nbsp; Kingdomway &nbsp;&nbsp;&nbsp; ABA Chemical &nbsp;&nbsp;&nbsp; Space Biology &nbsp;&nbsp;&nbsp; Kaneka &nbsp;&nbsp;&nbsp; NHU &nbsp;&nbsp;&nbsp; Yuxi Jiankun &nbsp;&nbsp;&nbsp; ZMC Key Questions Addressed in this Report What is the 10-year outlook for the global Raw Materials of Longevity Medicine market? What factors are driving Raw Materials of Longevity Medicine market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Raw Materials of Longevity Medicine market opportunities vary by end market size? How does Raw Materials of Longevity Medicine break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Raw Materials of Longevity Medicine Annual Sales 2021-2032 &nbsp;2.1.2 World Current & Future Analysis for Raw Materials of Longevity Medicine by Geographic Region, 2021, 2025 & 2032 &nbsp;2.1.3 World Current & Future Analysis for Raw Materials of Longevity Medicine by Country/Region, 2021, 2025 & 2032 &nbsp;2.2 Raw Materials of Longevity Medicine Segment by Type &nbsp;2.2.1 Purity ? 98% &nbsp;2.2.2 Purity < 98% &nbsp;2.2.3 Raw Materials of Longevity Medicine Sales by Type &nbsp;2.2.3.1 Global Raw Materials of Longevity Medicine Sales Market Share by Type (2021-2026) &nbsp;2.2.3.2 Global Raw Materials of Longevity Medicine Revenue and Market Share by Type (2021-2026) &nbsp;2.2.3.3 Global Raw Materials of Longevity Medicine Sale Price by Type (2021-2026) &nbsp;2.3 Raw Materials of Longevity Medicine Segment by Types of Raw Materials &nbsp;2.3.1 NMN (Nicotinamide Mononucleotide) &nbsp;2.3.2 NR (Nicotinamide Riboside) &nbsp;2.3.3 Resveratrol &nbsp;2.3.4 Metformin &nbsp;2.3.5 Astaxanthin &nbsp;2.3.6 Coenzyme Q10 &nbsp;2.3.7 Others &nbsp;2.3.8 Raw Materials of Longevity Medicine Sales by Types of Raw Materials &nbsp;2.3.8.1 Global Raw Materials of Longevity Medicine Sales Market Share by Types of Raw Materials (2021-2026) &nbsp;2.3.8.2 Global Raw Materials of Longevity Medicine Revenue and Market Share by Types of Raw Materials (2021-2026) &nbsp;2.3.8.3 Global Raw Materials of Longevity Medicine Sale Price by Types of Raw Materials (2021-2026) &nbsp;2.4 Raw Materials of Longevity Medicine Segment by Sources and Chemical Properties &nbsp;2.4.1 Natural Extracts &nbsp;2.4.2 Chemical Synthesis &nbsp;2.4.3 Others &nbsp;2.4.4 Raw Materials of Longevity Medicine Sales by Sources and Chemical Properties &nbsp;2.4.4.1 Global Raw Materials of Longevity Medicine Sales Market Share by Sources and Chemical Properties (2021-2026) &nbsp;2.4.4.2 Global Raw Materials of Longevity Medicine Revenue and Market Share by Sources and Chemical Properties (2021-2026) &nbsp;2.4.4.3 Global Raw Materials of Longevity Medicine Sale Price by Sources and Chemical Properties (2021-2026) &nbsp;2.5 Raw Materials of Longevity Medicine Segment by Application &nbsp;2.5.1 Health Products &nbsp;2.5.2 Medicines &nbsp;2.5.3 Others &nbsp;2.5.4 Raw Materials of Longevity Medicine Sales by Application &nbsp;2.5.4.1 Global Raw Materials of Longevity Medicine Sale Market Share by Application (2021-2026) &nbsp;2.5.4.2 Global Raw Materials of Longevity Medicine Revenue and Market Share by Application (2021-2026) &nbsp;2.5.4.3 Global Raw Materials of Longevity Medicine Sale Price by Application (2021-2026) 3 Global by Company &nbsp;3.1 Global Raw Materials of Longevity Medicine Breakdown Data by Company &nbsp;3.1.1 Global Raw Materials of Longevity Medicine Annual Sales by Company (2021-2026) &nbsp;3.1.2 Global Raw Materials of Longevity Medicine Sales Market Share by Company (2021-2026) &nbsp;3.2 Global Raw Materials of Longevity Medicine Annual Revenue by Company (2021-2026) &nbsp;3.2.1 Global Raw Materials of Longevity Medicine Revenue by Company (2021-2026) &nbsp;3.2.2 Global Raw Materials of Longevity Medicine Revenue Market Share by Company (2021-2026) &nbsp;3.3 Global Raw Materials of Longevity Medicine Sale Price by Company &nbsp;3.4 Key Manufacturers Raw Materials of Longevity Medicine Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Raw Materials of Longevity Medicine Product Location Distribution &nbsp;3.4.2 Players Raw Materials of Longevity Medicine Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Raw Materials of Longevity Medicine by Geographic Region &nbsp;4.1 World Historic Raw Materials of Longevity Medicine Market Size by Geographic Region (2021-2026) &nbsp;4.1.1 Global Raw Materials of Longevity Medicine Annual Sales by Geographic Region (2021-2026) &nbsp;4.1.2 Global Raw Materials of Longevity Medicine Annual Revenue by Geographic Region (2021-2026) &nbsp;4.2 World Historic Raw Materials of Longevity Medicine Market Size by Country/Region (2021-2026) &nbsp;4.2.1 Global Raw Materials of Longevity Medicine Annual Sales by Country/Region (2021-2026) &nbsp;4.2.2 Global Raw Materials of Longevity Medicine Annual Revenue by Country/Region (2021-2026) &nbsp;4.3 Americas Raw Materials of Longevity Medicine Sales Growth &nbsp;4.4 APAC Raw Materials of Longevity Medicine Sales Growth &nbsp;4.5 Europe Raw Materials of Longevity Medicine Sales Growth &nbsp;4.6 Middle East & Africa Raw Materials of Longevity Medicine Sales Growth 5 Americas &nbsp;5.1 Americas Raw Materials of Longevity Medicine Sales by Country &nbsp;5.1.1 Americas Raw Materials of Longevity Medicine Sales by Country (2021-2026) &nbsp;5.1.2 Americas Raw Materials of Longevity Medicine Revenue by Country (2021-2026) &nbsp;5.2 Americas Raw Materials of Longevity Medicine Sales by Type (2021-2026) &nbsp;5.3 Americas Raw Materials of Longevity Medicine Sales by Application (2021-2026) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Raw Materials of Longevity Medicine Sales by Region &nbsp;6.1.1 APAC Raw Materials of Longevity Medicine Sales by Region (2021-2026) &nbsp;6.1.2 APAC Raw Materials of Longevity Medicine Revenue by Region (2021-2026) &nbsp;6.2 APAC Raw Materials of Longevity Medicine Sales by Type (2021-2026) &nbsp;6.3 APAC Raw Materials of Longevity Medicine Sales by Application (2021-2026) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Raw Materials of Longevity Medicine by Country &nbsp;7.1.1 Europe Raw Materials of Longevity Medicine Sales by Country (2021-2026) &nbsp;7.1.2 Europe Raw Materials of Longevity Medicine Revenue by Country (2021-2026) &nbsp;7.2 Europe Raw Materials of Longevity Medicine Sales by Type (2021-2026) &nbsp;7.3 Europe Raw Materials of Longevity Medicine Sales by Application (2021-2026) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Raw Materials of Longevity Medicine by Country &nbsp;8.1.1 Middle East & Africa Raw Materials of Longevity Medicine Sales by Country (2021-2026) &nbsp;8.1.2 Middle East & Africa Raw Materials of Longevity Medicine Revenue by Country (2021-2026) &nbsp;8.2 Middle East & Africa Raw Materials of Longevity Medicine Sales by Type (2021-2026) &nbsp;8.3 Middle East & Africa Raw Materials of Longevity Medicine Sales by Application (2021-2026) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Raw Materials of Longevity Medicine &nbsp;10.3 Manufacturing Process Analysis of Raw Materials of Longevity Medicine &nbsp;10.4 Industry Chain Structure of Raw Materials of Longevity Medicine 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Raw Materials of Longevity Medicine Distributors &nbsp;11.3 Raw Materials of Longevity Medicine Customer 12 World Forecast Review for Raw Materials of Longevity Medicine by Geographic Region &nbsp;12.1 Global Raw Materials of Longevity Medicine Market Size Forecast by Region &nbsp;12.1.1 Global Raw Materials of Longevity Medicine Forecast by Region (2027-2032) &nbsp;12.1.2 Global Raw Materials of Longevity Medicine Annual Revenue Forecast by Region (2027-2032) &nbsp;12.2 Americas Forecast by Country (2027-2032) &nbsp;12.3 APAC Forecast by Region (2027-2032) &nbsp;12.4 Europe Forecast by Country (2027-2032) &nbsp;12.5 Middle East & Africa Forecast by Country (2027-2032) &nbsp;12.6 Global Raw Materials of Longevity Medicine Forecast by Type (2027-2032) &nbsp;12.7 Global Raw Materials of Longevity Medicine Forecast by Application (2027-2032) 13 Key Players Analysis &nbsp;13.1 DSM &nbsp;13.1.1 DSM Company Information &nbsp;13.1.2 DSM Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.1.3 DSM Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.1.4 DSM Main Business Overview &nbsp;13.1.5 DSM Latest Developments &nbsp;13.2 Evolva &nbsp;13.2.1 Evolva Company Information &nbsp;13.2.2 Evolva Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.2.3 Evolva Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.2.4 Evolva Main Business Overview &nbsp;13.2.5 Evolva Latest Developments &nbsp;13.3 Sabinsa &nbsp;13.3.1 Sabinsa Company Information &nbsp;13.3.2 Sabinsa Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.3.3 Sabinsa Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.3.4 Sabinsa Main Business Overview &nbsp;13.3.5 Sabinsa Latest Developments &nbsp;13.4 InterHealth &nbsp;13.4.1 InterHealth Company Information &nbsp;13.4.2 InterHealth Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.4.3 InterHealth Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.4.4 InterHealth Main Business Overview &nbsp;13.4.5 InterHealth Latest Developments &nbsp;13.5 Maypro &nbsp;13.5.1 Maypro Company Information &nbsp;13.5.2 Maypro Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.5.3 Maypro Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.5.4 Maypro Main Business Overview &nbsp;13.5.5 Maypro Latest Developments &nbsp;13.6 Laurus Labs &nbsp;13.6.1 Laurus Labs Company Information &nbsp;13.6.2 Laurus Labs Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.6.3 Laurus Labs Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.6.4 Laurus Labs Main Business Overview &nbsp;13.6.5 Laurus Labs Latest Developments &nbsp;13.7 JF-NATURAL &nbsp;13.7.1 JF-NATURAL Company Information &nbsp;13.7.2 JF-NATURAL Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.7.3 JF-NATURAL Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.7.4 JF-NATURAL Main Business Overview &nbsp;13.7.5 JF-NATURAL Latest Developments &nbsp;13.8 GeneHarbor &nbsp;13.8.1 GeneHarbor Company Information &nbsp;13.8.2 GeneHarbor Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.8.3 GeneHarbor Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.8.4 GeneHarbor Main Business Overview &nbsp;13.8.5 GeneHarbor Latest Developments &nbsp;13.9 Herbalmax &nbsp;13.9.1 Herbalmax Company Information &nbsp;13.9.2 Herbalmax Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.9.3 Herbalmax Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.9.4 Herbalmax Main Business Overview &nbsp;13.9.5 Herbalmax Latest Developments &nbsp;13.10 Genex Formulas &nbsp;13.10.1 Genex Formulas Company Information &nbsp;13.10.2 Genex Formulas Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.10.3 Genex Formulas Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.10.4 Genex Formulas Main Business Overview &nbsp;13.10.5 Genex Formulas Latest Developments &nbsp;13.11 Mirailab Bioscience &nbsp;13.11.1 Mirailab Bioscience Company Information &nbsp;13.11.2 Mirailab Bioscience Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.11.3 Mirailab Bioscience Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.11.4 Mirailab Bioscience Main Business Overview &nbsp;13.11.5 Mirailab Bioscience Latest Developments &nbsp;13.12 Maac10 Formulas &nbsp;13.12.1 Maac10 Formulas Company Information &nbsp;13.12.2 Maac10 Formulas Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.12.3 Maac10 Formulas Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.12.4 Maac10 Formulas Main Business Overview &nbsp;13.12.5 Maac10 Formulas Latest Developments &nbsp;13.13 EffePharm &nbsp;13.13.1 EffePharm Company Information &nbsp;13.13.2 EffePharm Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.13.3 EffePharm Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.13.4 EffePharm Main Business Overview &nbsp;13.13.5 EffePharm Latest Developments &nbsp;13.14 Bontac &nbsp;13.14.1 Bontac Company Information &nbsp;13.14.2 Bontac Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.14.3 Bontac Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.14.4 Bontac Main Business Overview &nbsp;13.14.5 Bontac Latest Developments &nbsp;13.15 CELFULL &nbsp;13.15.1 CELFULL Company Information &nbsp;13.15.2 CELFULL Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.15.3 CELFULL Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.15.4 CELFULL Main Business Overview &nbsp;13.15.5 CELFULL Latest Developments &nbsp;13.16 Kingdomway &nbsp;13.16.1 Kingdomway Company Information &nbsp;13.16.2 Kingdomway Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.16.3 Kingdomway Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.16.4 Kingdomway Main Business Overview &nbsp;13.16.5 Kingdomway Latest Developments &nbsp;13.17 ABA Chemical &nbsp;13.17.1 ABA Chemical Company Information &nbsp;13.17.2 ABA Chemical Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.17.3 ABA Chemical Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.17.4 ABA Chemical Main Business Overview &nbsp;13.17.5 ABA Chemical Latest Developments &nbsp;13.18 Space Biology &nbsp;13.18.1 Space Biology Company Information &nbsp;13.18.2 Space Biology Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.18.3 Space Biology Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.18.4 Space Biology Main Business Overview &nbsp;13.18.5 Space Biology Latest Developments &nbsp;13.19 Kaneka &nbsp;13.19.1 Kaneka Company Information &nbsp;13.19.2 Kaneka Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.19.3 Kaneka Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.19.4 Kaneka Main Business Overview &nbsp;13.19.5 Kaneka Latest Developments &nbsp;13.20 NHU &nbsp;13.20.1 NHU Company Information &nbsp;13.20.2 NHU Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.20.3 NHU Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.20.4 NHU Main Business Overview &nbsp;13.20.5 NHU Latest Developments &nbsp;13.21 Yuxi Jiankun &nbsp;13.21.1 Yuxi Jiankun Company Information &nbsp;13.21.2 Yuxi Jiankun Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.21.3 Yuxi Jiankun Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.21.4 Yuxi Jiankun Main Business Overview &nbsp;13.21.5 Yuxi Jiankun Latest Developments &nbsp;13.22 ZMC &nbsp;13.22.1 ZMC Company Information &nbsp;13.22.2 ZMC Raw Materials of Longevity Medicine Product Portfolios and Specifications &nbsp;13.22.3 ZMC Raw Materials of Longevity Medicine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.22.4 ZMC Main Business Overview &nbsp;13.22.5 ZMC Latest Developments 14 Research Findings and Conclusion

Report	Global Raw Materials of Longevity Medicine Market Growth 2026-2032
Selected License	Multi ID: ILR1629

Buyer Information

Order Summary